Standout Papers

Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice... 2019 2026 2021 2023 220
  1. Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice (2019)
    Qinyu Wang, Guomin Hu et al. British Journal of Pharmacology

Immediate Impact

33 standout
Sub-graph 1 of 16

Citing Papers

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
2024 Standout
A Survey of IoT Privacy Security: Architecture, Technology, Challenges, and Trends
2024 Standout
2 intermediate papers

Works of Cong Wen being referenced

Federated Learning for Intelligent Transmission with Space-Air-Ground Integrated Network toward 6G
2022
Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice
2019 Standout

Author Peers

Author Last Decade Papers Cites
Cong Wen 129 3 7 122 59 14 354
Yonghui Chen 56 4 29 62 31 349
Yilan Shen 201 54 36 19 410
Ke Pei 116 2 101 37 12 376
Shihai Cheng 89 1 100 31 10 355
Wenquan Zhang 134 1 33 8 21 356
Chenglong Ren 115 3 83 28 12 396
Mengqi Zhang 132 32 11 13 322
Lilei Zhao 133 145 59 12 304
Tapan Kumar Chakraborty 50 1 29 24 22 329
Lianjun Xing 140 1 149 73 22 338

All Works

Loading papers...

Rankless by CCL
2026